Early safety check for new oral drug GEn-1124
NCT ID NCT07185113
First seen Oct 31, 2025 · Last updated May 23, 2026 · Updated 37 times
Summary
This early-phase trial tested a single oral dose of GEn-1124 in 6 healthy adult men to see how the body absorbs, processes, and eliminates the drug. Researchers also monitored for side effects. The study is complete and provides initial safety and drug-level data.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT MALE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
New Zealand Clinical Research (NZCR)
Christchurch, 8011, New Zealand
Conditions
Explore the condition pages connected to this study.